Samsung Electronics Finalizes Xealth Acquisition

According to the announcement, Xealth will continue to operate under its existing brand, with its leadership team remaining in place.

Samsung Electronics has officially concluded its acquisition of Xealth, a U.S.-based digital health prescription platform that enables healthcare providers to prescribe, deliver, and monitor digital health tools through electronic health records (EHR). The agreement to acquire Xealth was first announced in July.

According to the announcement, Xealth will continue to operate under its existing brand, with its leadership team remaining in place. 

The company’s technology integrates digital health offerings into clinical workflows to enhance patient care and improve clinical efficiency across health systems.

Xealth’s suite of digital health solutions includes multimedia patient education, digital clinical assessments, remote patient monitoring programs, and virtual care referrals—tools designed to support patients before, during, and after their medical appointments.

Integration with EHR and Clinical Workflows

Xealth’s Digital Care SMART on FHIR app allows physicians and care teams to prescribe and monitor digital health tools directly from the EHR. The integration offers clinical decision support by matching patients with relevant digital programs and automatically enrolling them when appropriate.

The app can be downloaded from EHR app stores and configured to launch directly within the provider’s charting workflow, ensuring seamless access for clinicians. By leveraging EHR data, Xealth aims to streamline digital care delivery and improve engagement across care teams and patients.

“Samsung and the Xealth team will engage, learn, and support health systems, consumers, and digital health partners in creating a healthcare ecosystem that aims to improve the health of everyone,” said Dr. Hon Pak, senior vice president and head of the digital health team, Mobile eXperience Business at Samsung Electronics.

Mike McSherry, CEO and cofounder of Xealth, stated, “That driving force is supported and propelled through Samsung in a way that will bring truly connected care and add fresh context to the patient experience in a way not possible before. Together with Samsung and our network of healthcare leaders, we will design a bridge between home health monitoring and clinical decision-making, with provider workflows and the patient-provider relationship at the core.”

The acquisition builds on Samsung’s ongoing expansion in healthcare technology. In recent years, the company has collaborated with South Korean AI firms Lunit and VUNO to integrate AI-enabled diagnostic solutions into its premium X-ray and radiography systems deployed across the U.S., Canada, and Europe.

Earlier this year, Xealth received a strategic investment from Morningside Ventures to help health systems manage and deploy digital health formularies more efficiently. The platform has also been used by the Froedtert & Medical College of Wisconsin (MCW) network to engage patients with clinical nutrition programs for diabetes management through its digital health interface.

Stay tuned for more such updates on Digital Health News